ACUTE MYELOID LEUKEMIA, ADULT
Clinical trials for ACUTE MYELOID LEUKEMIA, ADULT explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOID LEUKEMIA, ADULT trials appear
Sign up with your email to follow new studies for ACUTE MYELOID LEUKEMIA, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to beat back stubborn leukemia
Disease control Recruiting nowThis study tests a combination of four drugs, called CLAG-GO, in adults whose acute myeloid leukemia (AML) has not responded to standard treatment or has come back after remission. Participants receive the drugs during a hospital stay, and if the cancer goes into remission, they …
Matched conditions: ACUTE MYELOID LEUKEMIA, ADULT
Phase: PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jul 02, 2026 03:00 UTC
-
New pill combo aims to tackle tough leukemia
Disease control Recruiting nowThis study is testing a new targeted drug called crifortinib besylate (taken as a pill) combined with standard chemotherapy in adults who have just been diagnosed with acute myeloid leukemia (AML). The trial has two phases: first, finding the best dose, then testing it in a large…
Matched conditions: ACUTE MYELOID LEUKEMIA, ADULT
Phase: PHASE1, PHASE2 • Sponsor: Sunshine Lake Pharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New hope for older AML patients: study tests smarter drug combos to beat relapse
Disease control Recruiting nowThis study compares four different drug combinations for adults newly diagnosed with acute myeloid leukemia (AML) who are not healthy enough for standard intensive chemotherapy or choose not to have it. The goal is to see which combination works best to keep the cancer away longe…
Matched conditions: ACUTE MYELOID LEUKEMIA, ADULT
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC